CRISPR Therapeutics (CRSP) market cap

Market cap today
$3.89B

CRISPR Therapeutics (CRSP) has a market cap of $3.89B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.72B. That is 42.0% higher than the $3.32B of fiscal 2024. Today's figure is 17.4% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$3.89B
Market cap, fiscal 2025
$4.72B
Change on fiscal 2024
+42.0%
Growth, 5 years
−14.1% a year
Highest on record
$10.10Bfiscal 2020
Lowest on record
$940.55Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

CRISPR Therapeutics market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 14.1% a year. Across the 9 fiscal year-ends on record (2017–2025), the highest was $10.10B in fiscal 2020 and the lowest $940.55M in fiscal 2017.

History · 9 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

CRISPR Therapeutics market cap, year by year

CRISPR Therapeutics (CRSP) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$3.89B—$40.15—
2025$4.72B 42.0% up$52.4489.93M
2024$3.32B 33.0% down$39.3684.36M
2023$4.96B 56.9% up$62.6079.22M
2022$3.16B 48.1% down$40.6577.75M
2021$6.09B 39.7% down$75.7880.39M
2020$10.10B 191.2% up$153.1165.95M
2019$3.47B 153.0% up$60.9056.93M
2018$1.37B 45.7% up$28.5747.96M
2017$940.55M—$23.4840.06M
2016——$20.26—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of CRISPR Therapeutics and comparable companies
CompanyMarket cap
MiniMed Group MMED$5.00B
Adaptive Biotechnologies ADPT$4.61B
Heartflow HTFL$4.14B
CRISPR Therapeutics CRSP$3.89B
Travere Therapeutics TVTX$4.91B
Option Care Health OPCH$4.74B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on CRSP

CRISPR Therapeutics, figure by figure

CRISPR Therapeutics (CRSP) overview: price, valuation and scorecardAll health care companies by market value

CRISPR Therapeutics market cap: questions and answers

What is CRISPR Therapeutics's market cap?

CRISPR Therapeutics (CRSP) has a market cap of $3.89B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.72B. That is 42.0% higher than the $3.32B of fiscal 2024.

What is the growth rate of CRISPR Therapeutics's market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 14.1% a year.

What are the highest and lowest market cap figures on record for CRISPR Therapeutics?

Across the 9 fiscal year-ends on record (2017–2025), the highest was $10.10B in fiscal 2020 and the lowest $940.55M in fiscal 2017.

How is CRISPR Therapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For CRISPR Therapeutics it is on record here for 9 fiscal years, 2017 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CRISPR Therapeutics (CRSP) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/CRSP/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.